Forbes |
Popis: Forbes - Pharma & Healthcare
|
||||||
How The Trump Administration Is Blocking Access To Home Care22:30 Trump promises maximum consumer choice in health care. Yet, he is making it harder to access home -based care favored by older adults and young people with disabilities. Genome Sequencing Solves Rare Disease Mysteries19:50 Clinical genome sequencing now delivers genetic diagnoses for about 1 in 4 suspected rare disease patients, guiding targeted care and shaping newborn screening worldwide. Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most14:27 Len is a gamechanging drug to prevent HIV infections, priced by Gilead at $28,200. Limited drug is available at cost to low-income countries. Research ethics are discussed. New Drug Targets Genetic Root Of Severe Pancreatitis15.dubna Quarterly RNA drug plozasiran turns off a liver gene, sharply lowering life‑threatening pancreatitis attacks in a rare genetic disorder. This Pill May Help Pancreatic Cancer Patients Live Longer15.dubna In this week’s edition of InnovationRx, we look at the top self-made healthcare entrepreneurs, the latest 30 Under 30 Science & Healthcare list, and more. The Racist Patient, Revisited15.dubna Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound15.dubna UnitedHealth Group earnings next week may signal whether health insurance companies are getting a handle on rising costs dragging down the industry. New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know14.dubna A new pancreatic cancer drug called daraxonrasib cut the risk of death by 60% in a Phase 3 trial. What it is, how it works, side effects and when it could reach patients. Why Sex Exists14.dubna Serially cloned mice hit a genetic “dead end” by generation 58, underscoring that sex evolved for variation, purging harmful mutations and keeping lineages viable. How Two Sisters Built A $1 Billion HealthTech Unicorn14.dubna Meet Chloe and Olivia Farro, the sibling co-founders behind SheMed, the UK’s first female-focused GLP-1 telehealth platform. In this interview, they sit down to discuss how they took their own frustrations with a dismissive healthcare system and turned them into a startup that recently raised $50 million at a $1 billion valuation. An AI System Passed Peer Review. The Scientific Community Isn’t Ready13.dubna An AI system automated the full arc of scientific research and passed peer review. Its creators say it could fix science's worst habits — but the risks are just as real. A Novel Approach To The Treatment Of Antibiotic Resistant Infections13.dubna Programmable cell‑like particles seek out drug‑resistant bacteria, inject lethal payloads, and spare beneficial microbes. Democrat-Leaning Plan Takes Aim At Health Insurers With Proposed New Regulations13.dubna Healthcare initiatives being proposed like Patients' Bill of Rights offer a roadmap for Democrats’ priorities, with midterms looming and a presidential election in 2028. Trump Administration Is Favoring Medicare Advantage Plans For Seniors13.dubna Trump administration is considering auto-enrollment for Medicare enrollees in Medicare Advantage. This suggests a preference for the program over traditional Medicare. Prior Authorization Reform Is Here—And It Could Change How Millions Get Care13.dubna Prior authorization forces doctors to spend 13 hours a week fighting insurers. New federal rules are changing that—here's what you need to know. |
Noviny
Sépie
Černé
Konzole
Modré
Přihlásit
Založit účet
Souhrn
Moje
Home
World
Sport
Economy
Technology
Culture
Life & Style
Other